Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
about
Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolismEnhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout micePronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout miceFgd5 identifies hematopoietic stem cells in the murine bone marrow.Morphological and functional platelet abnormalities in Berkeley sickle cell mice.Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice.The panoply of animal models for sickle cell anaemia.Pregnancy-secreted Acid phosphatase, uteroferrin, enhances fetal erythropoiesis.Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin geneVasculopathy and pulmonary hypertension in sickle cell disease.Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formationCorrection of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemiaHeme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C diseaseErythropoiesis in the absence of adult hemoglobin.Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene.Review paper: a review of the pathology of abnormal placentae of somatic cell nuclear transfer clone pregnancies in cattle, sheep, and mice.Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease.A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus.Gadd34 requirement for normal hemoglobin synthesis.Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion.Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.Deletion of a coordinate regulator of type 2 cytokine expression in mice.Mouse Models of Erythropoiesis and Associated Diseases.HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney.A tissue-specific self-interacting chromatin domain forms independently of enhancer-promoter interactions
P2860
Q24616407-2DD37180-5C56-4776-AAE8-1560BC3C569FQ24678512-08FA33C9-A13C-4117-A7BE-7FAC3272ACB1Q28513116-6AE7B8E5-DF92-43C3-9FCA-07B1892AD8BFQ30582103-71CAD9F8-9DAD-469B-B850-EF1CFBDC2A80Q33379114-E066AAE5-C2D4-48C1-B94E-ED92B875FB04Q33686611-49215400-3C87-459A-B10F-8F005FE39C34Q34135311-B57ADDA9-8194-4A02-BAFB-880B923A4614Q34343026-B489DE97-4131-4B17-B8C7-54623B004827Q34359790-AA65D1B7-38E3-4523-8A3E-4AF0E592BDF8Q34621789-D21E8773-3619-4F49-8647-DCF045B06F58Q35086394-B5CC5943-B82D-402A-9744-8AD6B398149AQ35849115-53DA8966-4884-4B72-9EEC-9DF3D2AE9A75Q36027459-5DE7413D-43E3-418E-8469-75A5AFB76207Q36757616-8BE03E65-0864-49E7-AAA2-C3B65E2C0668Q36812858-1B6F0C57-D2E5-4F96-A1C2-ACCC4E082282Q36827072-24C8DE26-B183-4C01-AE1E-39AD12E6D051Q37271697-A3EA52B9-4167-4E99-83FA-C3B73449A778Q37317744-969B83A9-ED94-4356-869C-E8137BBDF50BQ37361713-3ECEB5AA-2CDD-4090-B4C6-B5E917E33E06Q37363078-9AC192AE-34DA-4972-8BF3-4489F56E6BB2Q42137693-0C29F711-6759-443F-B7A9-61A8C032C0E9Q44241902-72AD1B00-B299-40BD-8837-CD971F661FADQ44788635-E2F7A43D-257F-4D6B-8EE1-AE60E48AF74FQ45998910-58419801-D72E-4384-B43B-0E5BBF7AF0C2Q46218974-66283D51-4096-4232-8AEB-52899B6A4521Q50093958-AC4CD07C-FAF3-4D1E-B40A-DB38C0F03289Q53618342-A2F700BD-137D-448C-8177-12BA52C9DD71Q58124035-A5C9AD9E-8DF4-4EDF-85DF-EEC5A4F3F3AC
P2860
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
description
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
articolo scientifico
@it
artículu científicu espublizáu en 1995
@ast
im September 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/09/01)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/09/01)
@nl
наукова стаття, опублікована у вересні 1995
@uk
name
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@ast
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@en
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@nl
type
label
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@ast
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@en
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@nl
prefLabel
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@ast
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@en
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@nl
P2093
P2860
P356
P1433
P1476
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue
@en
P2093
C. M. Brion
E. M. Rubin
J. F. Loring
M. E. Stevens
N. Mohandas
S. A. Liebhaber
P2860
P2888
P356
10.1038/NG0995-33
P407
P577
1995-09-01T00:00:00Z